NCT03485534View on ClinicalTrials.gov

Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

November 4, 2019

Study Completion Date

November 4, 2019

Conditions
Hepatitis B, Chronic
Interventions
DRUG

Tenofovir Disoproxil Fumarate

Viread 300mg

DRUG

Tenofovir Disoproxil

Virehepa 245mg

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

C&R Research, Inc.
All Listed Sponsors
collaborator

C&R Research, Inc.

INDUSTRY

lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY